These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of enhancement and image quality: different iodine concentrations for liver on 128-slice multidetector computed tomography in the same chronic liver disease patients. Jo BG, Song YG, Shim SG, Kim YW. Korean J Intern Med; 2016 May; 31(3):461-9. PubMed ID: 26701234 [Abstract] [Full Text] [Related]
6. MDCT of the pancreas: optimizing scanning delay with a bolus-tracking technique for pancreatic, peripancreatic vascular, and hepatic contrast enhancement. Kondo H, Kanematsu M, Goshima S, Miyoshi T, Shiratori Y, Onozuka M, Moriyama N, Bae KT. AJR Am J Roentgenol; 2007 Mar; 188(3):751-6. PubMed ID: 17312064 [Abstract] [Full Text] [Related]
12. Evaluation of hypervascular hepatocellular carcinoma in cirrhotic liver by means of helical CT: comparison of different contrast medium concentrations within the same patient. Sultana S, Morishita S, Awai K, Kawanaka K, Ohyama Y, Nakayama Y, Imuta M, Arakawa A, Yamashita Y. Radiat Med; 2003 Mar; 21(6):239-45. PubMed ID: 14743896 [Abstract] [Full Text] [Related]
13. MDCT of the liver and hypervascular hepatocellular carcinomas: optimizing scan delays for bolus-tracking techniques of hepatic arterial and portal venous phases. Goshima S, Kanematsu M, Kondo H, Yokoyama R, Miyoshi T, Nishibori H, Kato H, Hoshi H, Onozuka M, Moriyama N. AJR Am J Roentgenol; 2006 Jul; 187(1):W25-32. PubMed ID: 16794136 [Abstract] [Full Text] [Related]
16. MDCT of hypervascular hepatocellular carcinomas: a prospective study using contrast materials with different iodine concentrations. Yagyu Y, Awai K, Inoue M, Watai R, Sano T, Hasegawa H, Nishimura Y. AJR Am J Roentgenol; 2005 May; 184(5):1535-40. PubMed ID: 15855112 [Abstract] [Full Text] [Related]